SPECTRAL AI, INC. Restricted Stock or Unit Expense
SPECTRAL AI, INC. (MDAI) reported Restricted Stock or Unit Expense of $1.70 million for the 6-month period ending 2023-06-30, per its 8-K filed 2023-09-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2023-09-15
- 2023-06-30: Restricted Stock or Unit Expense 6 month $1.70M.
- 2022-06-30: Restricted Stock or Unit Expense 6 month $200.00K.
| Period end | Restricted Stock or Unit Expense 6 month |
|---|---|
| 2023-06-30 | $1.70M 8-K · filed 2023-09-15 |
| 2022-06-30 | $200.00K 8-K · filed 2023-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |